Browsing Tag
chronic obstructive pulmonary disease
11 posts
Cyclopharm secures major US Department of Defense contract for Technegas supply
Cyclopharm Limited, the Australian-based radiopharmaceutical company, has taken a significant step in its US expansion efforts by signing…
EMA approves Dupixent as first biologic for COPD with elevated eosinophils
The European Medicines Agency (EMA) has granted approval to Dupixent (dupilumab) as a novel add-on maintenance treatment for…
Understanding Chronic Obstructive Pulmonary Disease (COPD): A comprehensive guide
Chronic Obstructive Pulmonary Disease, or COPD, is a progressive lung condition that encompasses emphysema and chronic bronchitis, often…
Lupin, Mark Cuban’s Cost Plus Drugs and COPD Foundation boost COPD treatment access
In a significant healthcare development, global pharmaceutical giant Lupin Limited (Lupin) has entered into a groundbreaking collaboration with…
Lupin gets Health Canada approval for generic Spiriva for COPD treatment
Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to…
Lupin to acquire rights to Brovana and Xopenex HFA for $75m
Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate)…
Lupin bags UK approval for Lutio inhalation product for COPD treatment
Lupin through its subsidiary — Lupin Healthcare (UK) has secured approval from the UK Medicines and Healthcare products…
Zydus gets FDA approval for COPD drug Roflumilast Tablets
Zydus Group said that its subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and…
Lupin Limited gets approval for Luforbec 100/6 µg pMDI in UK
Lupin Limited said that its subsidiary Lupin Healthcare (UK) has secured approval from the Medicines and Healthcare products…
Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment
Glenmark Pharmaceutical has announced the UK launch of Tiogiva, a bioequivalent version of Tiotropium Bromide dry powder inhaler…